Preparation and Characterization of a Nanostructured Lipid Carrier-Based Formulation of Pioglitazone for Enhanced Antidiabetic Activity. Int. J. Environ. Sci. [Internet]. 2025 Jun. 15 [cited 2026 Apr. 4];11(10s):464-73. Available from: https://theaspd.com/index.php/ijes/article/view/1603